aluates Reports

$ 0.0

Automative

Global Acyclovir Analogues Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-9F19282

BUY CHAPTERS

Global Acyclovir Analogues Market Research Report 2025

Code: QYRE-Auto-9F19282

Report

March 2025

Pages:112

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Acyclovir Analogues Market Size

The global market for Acyclovir Analogues was valued at US$ 1841 million in the year 2024 and is projected to reach a revised size of US$ 2813 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Acyclovir Analogues Market

A class of antiviral drugs that are structurally related to acyclovir and share a similar mechanism of action by inhibiting viral DNA polymerase. These drugs are commonly used to treat herpesvirus infections, including herpes simplex virus (HSV), varicella-zoster virus (VZV), and cytomegalovirus (CMV). Examples include acyclovir, valacyclovir, penciclovir, and famciclovir.

North American market for Acyclovir Analogues is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Acyclovir Analogues is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Acyclovir Analogues in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Acyclovir Analogues include Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic, Cimed Industria de Medicamentos, Reman Drug, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Acyclovir Analogues, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acyclovir Analogues.

The Acyclovir Analogues market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acyclovir Analogues market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acyclovir Analogues companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Acyclovir Analogues Market Report

Report Metric	Details
Report Name	Acyclovir Analogues Market
Accounted market size in year	US$ 1841 million
Forecasted market size in 2031	US$ 2813 million
CAGR	6.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Acyclovir Valacyclovir Penciclovir Famciclovir Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic, Cimed Industria de Medicamentos, Reman Drug, L.E.T.I., Nichi-Iko Pharmaceutical, Choseido Pharmaceutical, Shiono Kemikaru, Towa Yakuhin, Wockhardt, Takata Pharmaceutical, Aliud, Amneal Pharma, Apotex, Arrow, Laboratoires Servier, Sanofi, Mylan, Orion Pharma, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acyclovir Analogues company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Acyclovir Analogues Market growing?

Ans: The Acyclovir Analogues Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Acyclovir Analogues Market size in 2031?

Ans: The Acyclovir Analogues Market size in 2031 will be US$ 2813 million.

Who are the main players in the Acyclovir Analogues Market report?

Ans: The main players in the Acyclovir Analogues Market are Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic, Cimed Industria de Medicamentos, Reman Drug, L.E.T.I., Nichi-Iko Pharmaceutical, Choseido Pharmaceutical, Shiono Kemikaru, Towa Yakuhin, Wockhardt, Takata Pharmaceutical, Aliud, Amneal Pharma, Apotex, Arrow, Laboratoires Servier, Sanofi, Mylan, Orion Pharma, Pfizer

What are the Application segmentation covered in the Acyclovir Analogues Market report?

Ans: The Applications covered in the Acyclovir Analogues Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Acyclovir Analogues Market report?

Ans: The Types covered in the Acyclovir Analogues Market report are Acyclovir, Valacyclovir, Penciclovir, Famciclovir, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acyclovir Analogues Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Acyclovir

1.2.3 Valacyclovir

1.2.4 Penciclovir

1.2.5 Famciclovir

1.2.6 Other

1.3 Market by Application

1.3.1 Global Acyclovir Analogues Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acyclovir Analogues Market Perspective (2020-2031)

2.2 Global Acyclovir Analogues Growth Trends by Region

2.2.1 Global Acyclovir Analogues Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Acyclovir Analogues Historic Market Size by Region (2020-2025)

2.2.3 Acyclovir Analogues Forecasted Market Size by Region (2026-2031)

2.3 Acyclovir Analogues Market Dynamics

2.3.1 Acyclovir Analogues Industry Trends

2.3.2 Acyclovir Analogues Market Drivers

2.3.3 Acyclovir Analogues Market Challenges

2.3.4 Acyclovir Analogues Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acyclovir Analogues Players by Revenue

3.1.1 Global Top Acyclovir Analogues Players by Revenue (2020-2025)

3.1.2 Global Acyclovir Analogues Revenue Market Share by Players (2020-2025)

3.2 Global Top Acyclovir Analogues Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Acyclovir Analogues Revenue

3.4 Global Acyclovir Analogues Market Concentration Ratio

3.4.1 Global Acyclovir Analogues Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acyclovir Analogues Revenue in 2024

3.5 Global Key Players of Acyclovir Analogues Head office and Area Served

3.6 Global Key Players of Acyclovir Analogues, Product and Application

3.7 Global Key Players of Acyclovir Analogues, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Acyclovir Analogues Breakdown Data by Type

4.1 Global Acyclovir Analogues Historic Market Size by Type (2020-2025)

4.2 Global Acyclovir Analogues Forecasted Market Size by Type (2026-2031)

5 Acyclovir Analogues Breakdown Data by Application

5.1 Global Acyclovir Analogues Historic Market Size by Application (2020-2025)

5.2 Global Acyclovir Analogues Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Acyclovir Analogues Market Size (2020-2031)

6.2 North America Acyclovir Analogues Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Acyclovir Analogues Market Size by Country (2020-2025)

6.4 North America Acyclovir Analogues Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acyclovir Analogues Market Size (2020-2031)

7.2 Europe Acyclovir Analogues Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Acyclovir Analogues Market Size by Country (2020-2025)

7.4 Europe Acyclovir Analogues Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acyclovir Analogues Market Size (2020-2031)

8.2 Asia-Pacific Acyclovir Analogues Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Acyclovir Analogues Market Size by Region (2020-2025)

8.4 Asia-Pacific Acyclovir Analogues Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Acyclovir Analogues Market Size (2020-2031)

9.2 Latin America Acyclovir Analogues Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Acyclovir Analogues Market Size by Country (2020-2025)

9.4 Latin America Acyclovir Analogues Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acyclovir Analogues Market Size (2020-2031)

10.2 Middle East & Africa Acyclovir Analogues Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Acyclovir Analogues Market Size by Country (2020-2025)

10.4 Middle East & Africa Acyclovir Analogues Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Greater Pharma

11.1.1 Greater Pharma Company Details

11.1.2 Greater Pharma Business Overview

11.1.3 Greater Pharma Acyclovir Analogues Introduction

11.1.4 Greater Pharma Revenue in Acyclovir Analogues Business (2020-2025)

11.1.5 Greater Pharma Recent Development

11.2 LBS Labs

11.2.1 LBS Labs Company Details

11.2.2 LBS Labs Business Overview

11.2.3 LBS Labs Acyclovir Analogues Introduction

11.2.4 LBS Labs Revenue in Acyclovir Analogues Business (2020-2025)

11.2.5 LBS Labs Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Acyclovir Analogues Introduction

11.3.4 GlaxoSmithKline Revenue in Acyclovir Analogues Business (2020-2025)

11.3.5 GlaxoSmithKline Recent Development

11.4 Lex Ano

11.4.1 Lex Ano Company Details

11.4.2 Lex Ano Business Overview

11.4.3 Lex Ano Acyclovir Analogues Introduction

11.4.4 Lex Ano Revenue in Acyclovir Analogues Business (2020-2025)

11.4.5 Lex Ano Recent Development

11.5 Salutas

11.5.1 Salutas Company Details

11.5.2 Salutas Business Overview

11.5.3 Salutas Acyclovir Analogues Introduction

11.5.4 Salutas Revenue in Acyclovir Analogues Business (2020-2025)

11.5.5 Salutas Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Acyclovir Analogues Introduction

11.6.4 Novartis Revenue in Acyclovir Analogues Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Teva

11.7.1 Teva Company Details

11.7.2 Teva Business Overview

11.7.3 Teva Acyclovir Analogues Introduction

11.7.4 Teva Revenue in Acyclovir Analogues Business (2020-2025)

11.7.5 Teva Recent Development

11.8 Stada Nordic

11.8.1 Stada Nordic Company Details

11.8.2 Stada Nordic Business Overview

11.8.3 Stada Nordic Acyclovir Analogues Introduction

11.8.4 Stada Nordic Revenue in Acyclovir Analogues Business (2020-2025)

11.8.5 Stada Nordic Recent Development

11.9 Cimed Industria de Medicamentos

11.9.1 Cimed Industria de Medicamentos Company Details

11.9.2 Cimed Industria de Medicamentos Business Overview

11.9.3 Cimed Industria de Medicamentos Acyclovir Analogues Introduction

11.9.4 Cimed Industria de Medicamentos Revenue in Acyclovir Analogues Business (2020-2025)

11.9.5 Cimed Industria de Medicamentos Recent Development

11.10 Reman Drug

11.10.1 Reman Drug Company Details

11.10.2 Reman Drug Business Overview

11.10.3 Reman Drug Acyclovir Analogues Introduction

11.10.4 Reman Drug Revenue in Acyclovir Analogues Business (2020-2025)

11.10.5 Reman Drug Recent Development

11.11 L.E.T.I.

11.11.1 L.E.T.I. Company Details

11.11.2 L.E.T.I. Business Overview

11.11.3 L.E.T.I. Acyclovir Analogues Introduction

11.11.4 L.E.T.I. Revenue in Acyclovir Analogues Business (2020-2025)

11.11.5 L.E.T.I. Recent Development

11.12 Nichi-Iko Pharmaceutical

11.12.1 Nichi-Iko Pharmaceutical Company Details

11.12.2 Nichi-Iko Pharmaceutical Business Overview

11.12.3 Nichi-Iko Pharmaceutical Acyclovir Analogues Introduction

11.12.4 Nichi-Iko Pharmaceutical Revenue in Acyclovir Analogues Business (2020-2025)

11.12.5 Nichi-Iko Pharmaceutical Recent Development

11.13 Choseido Pharmaceutical

11.13.1 Choseido Pharmaceutical Company Details

11.13.2 Choseido Pharmaceutical Business Overview

11.13.3 Choseido Pharmaceutical Acyclovir Analogues Introduction

11.13.4 Choseido Pharmaceutical Revenue in Acyclovir Analogues Business (2020-2025)

11.13.5 Choseido Pharmaceutical Recent Development

11.14 Shiono Kemikaru

11.14.1 Shiono Kemikaru Company Details

11.14.2 Shiono Kemikaru Business Overview

11.14.3 Shiono Kemikaru Acyclovir Analogues Introduction

11.14.4 Shiono Kemikaru Revenue in Acyclovir Analogues Business (2020-2025)

11.14.5 Shiono Kemikaru Recent Development

11.15 Towa Yakuhin

11.15.1 Towa Yakuhin Company Details

11.15.2 Towa Yakuhin Business Overview

11.15.3 Towa Yakuhin Acyclovir Analogues Introduction

11.15.4 Towa Yakuhin Revenue in Acyclovir Analogues Business (2020-2025)

11.15.5 Towa Yakuhin Recent Development

11.16 Wockhardt

11.16.1 Wockhardt Company Details

11.16.2 Wockhardt Business Overview

11.16.3 Wockhardt Acyclovir Analogues Introduction

11.16.4 Wockhardt Revenue in Acyclovir Analogues Business (2020-2025)

11.16.5 Wockhardt Recent Development

11.17 Takata Pharmaceutical

11.17.1 Takata Pharmaceutical Company Details

11.17.2 Takata Pharmaceutical Business Overview

11.17.3 Takata Pharmaceutical Acyclovir Analogues Introduction

11.17.4 Takata Pharmaceutical Revenue in Acyclovir Analogues Business (2020-2025)

11.17.5 Takata Pharmaceutical Recent Development

11.18 Aliud

11.18.1 Aliud Company Details

11.18.2 Aliud Business Overview

11.18.3 Aliud Acyclovir Analogues Introduction

11.18.4 Aliud Revenue in Acyclovir Analogues Business (2020-2025)

11.18.5 Aliud Recent Development

11.19 Amneal Pharma

11.19.1 Amneal Pharma Company Details

11.19.2 Amneal Pharma Business Overview

11.19.3 Amneal Pharma Acyclovir Analogues Introduction

11.19.4 Amneal Pharma Revenue in Acyclovir Analogues Business (2020-2025)

11.19.5 Amneal Pharma Recent Development

11.20 Apotex

11.20.1 Apotex Company Details

11.20.2 Apotex Business Overview

11.20.3 Apotex Acyclovir Analogues Introduction

11.20.4 Apotex Revenue in Acyclovir Analogues Business (2020-2025)

11.20.5 Apotex Recent Development

11.21 Arrow

11.21.1 Arrow Company Details

11.21.2 Arrow Business Overview

11.21.3 Arrow Acyclovir Analogues Introduction

11.21.4 Arrow Revenue in Acyclovir Analogues Business (2020-2025)

11.21.5 Arrow Recent Development

11.22 Laboratoires Servier

11.22.1 Laboratoires Servier Company Details

11.22.2 Laboratoires Servier Business Overview

11.22.3 Laboratoires Servier Acyclovir Analogues Introduction

11.22.4 Laboratoires Servier Revenue in Acyclovir Analogues Business (2020-2025)

11.22.5 Laboratoires Servier Recent Development

11.23 Sanofi

11.23.1 Sanofi Company Details

11.23.2 Sanofi Business Overview

11.23.3 Sanofi Acyclovir Analogues Introduction

11.23.4 Sanofi Revenue in Acyclovir Analogues Business (2020-2025)

11.23.5 Sanofi Recent Development

11.24 Mylan

11.24.1 Mylan Company Details

11.24.2 Mylan Business Overview

11.24.3 Mylan Acyclovir Analogues Introduction

11.24.4 Mylan Revenue in Acyclovir Analogues Business (2020-2025)

11.24.5 Mylan Recent Development

11.25 Orion Pharma

11.25.1 Orion Pharma Company Details

11.25.2 Orion Pharma Business Overview

11.25.3 Orion Pharma Acyclovir Analogues Introduction

11.25.4 Orion Pharma Revenue in Acyclovir Analogues Business (2020-2025)

11.25.5 Orion Pharma Recent Development

11.26 Pfizer

11.26.1 Pfizer Company Details

11.26.2 Pfizer Business Overview

11.26.3 Pfizer Acyclovir Analogues Introduction

11.26.4 Pfizer Revenue in Acyclovir Analogues Business (2020-2025)

11.26.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Acyclovir Analogues Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Acyclovir

Table 3. Key Players of Valacyclovir

Table 4. Key Players of Penciclovir

Table 5. Key Players of Famciclovir

Table 6. Key Players of Other

Table 7. Global Acyclovir Analogues Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Acyclovir Analogues Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Acyclovir Analogues Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Acyclovir Analogues Market Share by Region (2020-2025)

Table 11. Global Acyclovir Analogues Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Acyclovir Analogues Market Share by Region (2026-2031)

Table 13. Acyclovir Analogues Market Trends

Table 14. Acyclovir Analogues Market Drivers

Table 15. Acyclovir Analogues Market Challenges

Table 16. Acyclovir Analogues Market Restraints

Table 17. Global Acyclovir Analogues Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Acyclovir Analogues Market Share by Players (2020-2025)

Table 19. Global Top Acyclovir Analogues Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acyclovir Analogues as of 2024)

Table 20. Ranking of Global Top Acyclovir Analogues Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Acyclovir Analogues Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Acyclovir Analogues, Headquarters and Area Served

Table 23. Global Key Players of Acyclovir Analogues, Product and Application

Table 24. Global Key Players of Acyclovir Analogues, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Acyclovir Analogues Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Acyclovir Analogues Revenue Market Share by Type (2020-2025)

Table 28. Global Acyclovir Analogues Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Acyclovir Analogues Revenue Market Share by Type (2026-2031)

Table 30. Global Acyclovir Analogues Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Acyclovir Analogues Revenue Market Share by Application (2020-2025)

Table 32. Global Acyclovir Analogues Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Acyclovir Analogues Revenue Market Share by Application (2026-2031)

Table 34. North America Acyclovir Analogues Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Acyclovir Analogues Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Acyclovir Analogues Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Acyclovir Analogues Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Acyclovir Analogues Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Acyclovir Analogues Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Acyclovir Analogues Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Acyclovir Analogues Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Acyclovir Analogues Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Acyclovir Analogues Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Acyclovir Analogues Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Acyclovir Analogues Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Acyclovir Analogues Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Acyclovir Analogues Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Acyclovir Analogues Market Size by Country (2026-2031) & (US$ Million)

Table 49. Greater Pharma Company Details

Table 50. Greater Pharma Business Overview

Table 51. Greater Pharma Acyclovir Analogues Product

Table 52. Greater Pharma Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 53. Greater Pharma Recent Development

Table 54. LBS Labs Company Details

Table 55. LBS Labs Business Overview

Table 56. LBS Labs Acyclovir Analogues Product

Table 57. LBS Labs Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 58. LBS Labs Recent Development

Table 59. GlaxoSmithKline Company Details

Table 60. GlaxoSmithKline Business Overview

Table 61. GlaxoSmithKline Acyclovir Analogues Product

Table 62. GlaxoSmithKline Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 63. GlaxoSmithKline Recent Development

Table 64. Lex Ano Company Details

Table 65. Lex Ano Business Overview

Table 66. Lex Ano Acyclovir Analogues Product

Table 67. Lex Ano Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 68. Lex Ano Recent Development

Table 69. Salutas Company Details

Table 70. Salutas Business Overview

Table 71. Salutas Acyclovir Analogues Product

Table 72. Salutas Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 73. Salutas Recent Development

Table 74. Novartis Company Details

Table 75. Novartis Business Overview

Table 76. Novartis Acyclovir Analogues Product

Table 77. Novartis Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 78. Novartis Recent Development

Table 79. Teva Company Details

Table 80. Teva Business Overview

Table 81. Teva Acyclovir Analogues Product

Table 82. Teva Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 83. Teva Recent Development

Table 84. Stada Nordic Company Details

Table 85. Stada Nordic Business Overview

Table 86. Stada Nordic Acyclovir Analogues Product

Table 87. Stada Nordic Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 88. Stada Nordic Recent Development

Table 89. Cimed Industria de Medicamentos Company Details

Table 90. Cimed Industria de Medicamentos Business Overview

Table 91. Cimed Industria de Medicamentos Acyclovir Analogues Product

Table 92. Cimed Industria de Medicamentos Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 93. Cimed Industria de Medicamentos Recent Development

Table 94. Reman Drug Company Details

Table 95. Reman Drug Business Overview

Table 96. Reman Drug Acyclovir Analogues Product

Table 97. Reman Drug Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 98. Reman Drug Recent Development

Table 99. L.E.T.I. Company Details

Table 100. L.E.T.I. Business Overview

Table 101. L.E.T.I. Acyclovir Analogues Product

Table 102. L.E.T.I. Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 103. L.E.T.I. Recent Development

Table 104. Nichi-Iko Pharmaceutical Company Details

Table 105. Nichi-Iko Pharmaceutical Business Overview

Table 106. Nichi-Iko Pharmaceutical Acyclovir Analogues Product

Table 107. Nichi-Iko Pharmaceutical Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 108. Nichi-Iko Pharmaceutical Recent Development

Table 109. Choseido Pharmaceutical Company Details

Table 110. Choseido Pharmaceutical Business Overview

Table 111. Choseido Pharmaceutical Acyclovir Analogues Product

Table 112. Choseido Pharmaceutical Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 113. Choseido Pharmaceutical Recent Development

Table 114. Shiono Kemikaru Company Details

Table 115. Shiono Kemikaru Business Overview

Table 116. Shiono Kemikaru Acyclovir Analogues Product

Table 117. Shiono Kemikaru Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 118. Shiono Kemikaru Recent Development

Table 119. Towa Yakuhin Company Details

Table 120. Towa Yakuhin Business Overview

Table 121. Towa Yakuhin Acyclovir Analogues Product

Table 122. Towa Yakuhin Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 123. Towa Yakuhin Recent Development

Table 124. Wockhardt Company Details

Table 125. Wockhardt Business Overview

Table 126. Wockhardt Acyclovir Analogues Product

Table 127. Wockhardt Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 128. Wockhardt Recent Development

Table 129. Takata Pharmaceutical Company Details

Table 130. Takata Pharmaceutical Business Overview

Table 131. Takata Pharmaceutical Acyclovir Analogues Product

Table 132. Takata Pharmaceutical Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 133. Takata Pharmaceutical Recent Development

Table 134. Aliud Company Details

Table 135. Aliud Business Overview

Table 136. Aliud Acyclovir Analogues Product

Table 137. Aliud Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 138. Aliud Recent Development

Table 139. Amneal Pharma Company Details

Table 140. Amneal Pharma Business Overview

Table 141. Amneal Pharma Acyclovir Analogues Product

Table 142. Amneal Pharma Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 143. Amneal Pharma Recent Development

Table 144. Apotex Company Details

Table 145. Apotex Business Overview

Table 146. Apotex Acyclovir Analogues Product

Table 147. Apotex Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 148. Apotex Recent Development

Table 149. Arrow Company Details

Table 150. Arrow Business Overview

Table 151. Arrow Acyclovir Analogues Product

Table 152. Arrow Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 153. Arrow Recent Development

Table 154. Laboratoires Servier Company Details

Table 155. Laboratoires Servier Business Overview

Table 156. Laboratoires Servier Acyclovir Analogues Product

Table 157. Laboratoires Servier Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 158. Laboratoires Servier Recent Development

Table 159. Sanofi Company Details

Table 160. Sanofi Business Overview

Table 161. Sanofi Acyclovir Analogues Product

Table 162. Sanofi Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 163. Sanofi Recent Development

Table 164. Mylan Company Details

Table 165. Mylan Business Overview

Table 166. Mylan Acyclovir Analogues Product

Table 167. Mylan Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 168. Mylan Recent Development

Table 169. Orion Pharma Company Details

Table 170. Orion Pharma Business Overview

Table 171. Orion Pharma Acyclovir Analogues Product

Table 172. Orion Pharma Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 173. Orion Pharma Recent Development

Table 174. Pfizer Company Details

Table 175. Pfizer Business Overview

Table 176. Pfizer Acyclovir Analogues Product

Table 177. Pfizer Revenue in Acyclovir Analogues Business (2020-2025) & (US$ Million)

Table 178. Pfizer Recent Development

Table 179. Research Programs/Design for This Report

Table 180. Key Data Information from Secondary Sources

Table 181. Key Data Information from Primary Sources

Table 182. Authors List of This Report

List of Figures

Figure 1. Acyclovir Analogues Picture

Figure 2. Global Acyclovir Analogues Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Acyclovir Analogues Market Share by Type: 2024 VS 2031

Figure 4. Acyclovir Features

Figure 5. Valacyclovir Features

Figure 6. Penciclovir Features

Figure 7. Famciclovir Features

Figure 8. Other Features

Figure 9. Global Acyclovir Analogues Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Acyclovir Analogues Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Other Case Studies

Figure 14. Acyclovir Analogues Report Years Considered

Figure 15. Global Acyclovir Analogues Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Acyclovir Analogues Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Acyclovir Analogues Market Share by Region: 2024 VS 2031

Figure 18. Global Acyclovir Analogues Market Share by Players in 2024

Figure 19. Global Acyclovir Analogues Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Acyclovir Analogues Revenue in 2024

Figure 21. North America Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Acyclovir Analogues Market Share by Country (2020-2031)

Figure 23. United States Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Acyclovir Analogues Market Share by Country (2020-2031)

Figure 27. Germany Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Acyclovir Analogues Market Share by Region (2020-2031)

Figure 35. China Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Acyclovir Analogues Market Share by Country (2020-2031)

Figure 43. Mexico Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Acyclovir Analogues Market Share by Country (2020-2031)

Figure 47. Turkey Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Acyclovir Analogues Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Greater Pharma Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 51. LBS Labs Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 52. GlaxoSmithKline Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 53. Lex Ano Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 54. Salutas Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 56. Teva Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 57. Stada Nordic Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 58. Cimed Industria de Medicamentos Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 59. Reman Drug Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 60. L.E.T.I. Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 61. Nichi-Iko Pharmaceutical Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 62. Choseido Pharmaceutical Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 63. Shiono Kemikaru Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 64. Towa Yakuhin Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 65. Wockhardt Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 66. Takata Pharmaceutical Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 67. Aliud Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 68. Amneal Pharma Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 69. Apotex Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 70. Arrow Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 71. Laboratoires Servier Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 72. Sanofi Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 73. Mylan Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 74. Orion Pharma Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 75. Pfizer Revenue Growth Rate in Acyclovir Analogues Business (2020-2025)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Acyclovir Active Pharmaceutical Ingredient API Market Research Report 2025

Global Aciclovir Market Research Report 2024

Global Acyclovir Intermediate Market Research Report 2025

Valaciclovir HCl Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diacetylacyclovir Market Research Report 2025

Global Acyclovir for Injection Market Research Report 2024

Global Valacyclovir API Market Research Report 2025

Global Nucleoside Antiviral Drugs Market Research Report 2025

Global Acyclovir Injection Market Research Report 2024

Acyclovir Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Valganciclovir API Market Research Report 2025

Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Aciclovir Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Valganciclovir Market Insights Forecast to 2030

Global Acyclovir Sodium Injection Market Research Report 2025

Global Oral Adefovir Drugs Market Research Report 2024

Global Human Papillomavirus and Cytomegalovirus Therapeutics Market Research Report 2024

Global Valganciclovir Tablets Market Research Report 2024

Global Penciclovir Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Acyclovir Analogues Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-9F19282

Global Acyclovir Analogues Market Research Report 2025

FEATURED COMPANIES

Acyclovir Analogues Market Size

Acyclovir Analogues Market

Scope of Acyclovir Analogues Market Report

Chapter Outline

FAQ for this report

How fast is Acyclovir Analogues Market growing?

What is the Acyclovir Analogues Market size in 2031?

Who are the main players in the Acyclovir Analogues Market report?

What are the Application segmentation covered in the Acyclovir Analogues Market report?

What are the Type segmentation covered in the Acyclovir Analogues Market report?

FEATURED COMPANIES

RELATED REPORTS